Background: Underfeeding with enteral nutrition (EN) is prevalent in intensive care units (ICUs) and associated with negative outcomes. This study evaluated the impact of volume-based EN (VBEN) vs rate-based EN (RBEN) on delivery of prescribed energy and protein, and glycemic control (GC). Methods: This retrospective study included adult patients who require mechanical ventilation within 48 hours of ICU admission and with an RBEN (n = 85) or VBEN (n = 86) order for ࣙ3 consecutive days during the first 12 ICU days. Results: Patients receiving VBEN, vs RBEN, received more prescribed energy (RBEN, 67.6%; VBEN, 79.6%; P < .001) and protein (RBEN, 68.6%; VBEN, 79.3%; P < .001). Multiple linear regression analyses confirmed VBEN was significantly associated with an 8.9% increase in energy (P = .002) and 7.7% increase in protein (P = .004) received, after adjusting for age, Acute Physiology and Chronic Health Evaluation II score, duration of and initiation day for EN, and ICU admission location. Presence of hyperglycemia (P = .40) and glycemic variability (GV) (P = .99) were not different between the 2 groups. After adjusting for age, body mass index, diabetes history, primary diagnosis, and percent of days receiving corticosteroids, GC outcomes (presence of hyperglycemia, P = .27; GV, P = .67) remained unrelated to EN order type in multivariable regression models. Conclusion: VBEN, compared with RBEN, was associated with increased energy and protein delivery without adversely affecting GC. These results suggest VBEN is an effective, safe strategy to enhance EN delivery in the ICU. (JPEN J Parenter Enteral Nutr. 2019;43:365-375) 
Introduction
Critically ill patients experience metabolic changes, hypermetabolism, and concomitant loss of lean body mass. [1] [2] [3] [4] Malnutrition, which is prevalent in the intensive care unit (ICU), contributes to negative consequences including increased healthcare costs, morbidity, and mortality. 5, 6 Because most ICU patients cannot meet their nutrition needs orally, nutrition support therapy (NST), via enteral nutrition (EN) or parenteral nutrition (PN), is standard care. 3 EN is the preferred NST route unless a health condition dictates use of PN. 3 However, underfeeding is common with EN, frequently because of EN interruptions that occur for multiple reasons including diagnostic tests and procedures. [7] [8] [9] [10] Underfeeding is of concern because it has been associated with worse clinical outcomes, including mortality. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Strategies to overcome nutrition deficits caused by interruptions have been developed to improve EN delivery. [24] [25] [26] [27] Volume-based EN (VBEN) is one strategy used to compensate for EN interruptions. 24, [28] [29] [30] [31] [32] [33] [34] [35] [36] VBEN uses an order for 24 hours (eg, 1200 mL/24 h) vs the traditional hourly infusion rate with rate-based EN (RBEN; eg, 50 mL/h). These are examples; usual rates and volumes are based on individual patient nutrient requirements. VBEN uses a nurse-driven algorithm to increase the EN infusion rate after interruptions ( Figure 1 ). 24, 34 Several studies have assessed effectiveness of VBEN vs RBEN in regard to EN delivery and complications 24, [28] [29] [30] [31] 33, 35, 36 ; to date, they suggest that VBEN, compared with RBEN, increases EN delivery without increasing complications. 24, [28] [29] [30] [31] [33] [34] [35] [36] However, most studies are limited by small sample size 24, 29, 33, 35 or lack of adjustment for potential confounding factors. 24, 28, 33, 35, 36 In addition, results regarding the impact of VBEN on increasing delivery of prescribed EN are inconsistent. 24, [28] [29] [30] [31] 33, 35, 36 These limitations warrant further examination of the effect of VBEN on EN delivery.
Because VBEN can substantially increase the infusion rate, VBEN may increase hyperglycemia and glycemic variability (GV). GV, which measures the degree of fluctuation between high and low blood glucose levels using all measured levels, is a more comprehensive method of evaluating glycemic control (GC) compared with individual blood glucose levels. 37 Both hyperglycemia and GV are undesirable in the ICU because they are associated with negative patient outcomes, including increased mortality. [38] [39] [40] [41] [42] [43] [44] Several studies have examined the association between VBEN and hyperglycemia, but none has demonstrated VBEN, compared with RBEN, increases in the incidence of hyperglycemia. 24, 28, 31, [34] [35] [36] However, GC equivalence was based solely on the first morning blood glucose level. This narrow focus may be an unreliable way to assess whether VBEN negatively influences GC. Because there is no known information on whether VBEN impacts GV, additional study of the relationship between VBEN and GC is warranted. This study's aim was to determine whether VBEN, compared with RBEN, increased delivery of prescribed energy and protein, and whether VBEN vs RBEN is associated with the presence of hyperglycemia or GV. We hypothesized that VBEN, compared with RBEN, would increase the percent of prescribed energy and protein delivered without adversely affecting GC outcomes.
Methods

Nutrition Practices at Study Location
This study took place at Baylor University Medical Center (BUMC), a 1000-bed teaching hospital located in Dallas, Texas. VBEN was implemented in August 2010 because previous BUMC research found suboptimal delivery of 60% of prescribed EN. 7, 45, 46 A pilot study in 2014 34 and internal audits (unpublished data) from 2016 to 2017 at BUMC demonstrated VBEN increased prescribed volume of EN delivered to a mean of 67% and 84%, respectively. Over the past 7 years, educational initiatives for nurses, enhanced access to the feeding algorithm (Figure 1) , and monthly audits were completed to improve VBEN order compliance. The mechanical ventilation (MV) order set, to
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3 Formula selection was based on patients' unique nutrition requirements.
BUMC's GC orders aim to maintain blood glucose levels between 70 and 150 mg/dL. When patients' blood glucose levels are consistently >200 mg/dL, a continuous insulin drip is initiated. GC orders were not different for patients receiving RBEN vs VBEN.
Patient Eligibility Criteria
Eligible patients were identified from an electronic health record (EHR) Active Tube Feeding Orders Report generated to capture ICU patients receiving EN from January 1, 2015 to February 28, 2017. The study included patients ࣙ18 years of age who required MV within 48 hours of ICU admission, had an ICU stay ࣙ72 hours, and had an RBEN or VBEN order for ࣙ3 consecutive days during the first 12 days in the ICU. According to hospital procedure and the MV order set, ICU patients were allowed to receive RBEN for up to 2 days before completion of the nutrition assessment. Then, patients either transitioned to VBEN or continued to receive RBEN if the RDN anticipated intolerance because of gastrointestinal dysfunction, refeeding syndrome risk, or need for escalating doses of vasopressors. Therefore, because many patients initially had an RBEN order, patients were allowed in the study and were included in the VBEN group if they had an initial RBEN order for ࣘ2 days followed by a VBEN order for ࣙ3 consecutive days. The inclusion and exclusion criteria ( Figure 2 ) were designed to ensure exposure to RBEN or VBEN. Patients were excluded if they received PN, had a do not resuscitate or comfort measures-only order at admission, were missing data for EN delivery or blood glucose levels for >2 days, or were not admitted directly to the ICU.
Study Design and Data Collection
This was an analysis of data collected or calculated from information in the patients' EHR (Sunrise 
Definition of RBEN and VBEN
VBEN orders were written for a 24-hour period (eg, 1200 mL/d) with a maximum compensatory rate of 150 mL/h ( Figure 1 ). 35 RBEN orders were written as volume per hour (eg, 50 mL/h) without any compensatory rate increase for interruptions. The MV order set or treating RDN determined the EN order type and initial EN rate and progression. Both RBEN and VBEN orders permitted starting EN at goal rate or initiating at 20 mL/h with a 20-mL/h rate increase every 8 hours until goal rate was attained.
Primary Outcomes
EN-related outcomes (percent of prescribed energy and grams of protein delivered) and GC outcomes (days with no hyperglycemia vs ࣙ1 days with hyperglycemia and GV) were evaluated. The EN-related outcomes were calculated by dividing the amount delivered by the amount prescribed. Hyperglycemia was defined as a blood glucose level >180 mg/dL based on the first morning blood glucose level. GV was measured using the glucose coefficient of variation (CV) (GlucoseCV [%] = glucose SD × 100/mean glucose level [mg/dL]). 44 GV was calculated using all blood glucose levels from day of EN initiation through ICU day 12, discharge from ICU, death, or EN discontinuation, whichever came first.
Sample Size and Statistical Analysis
A power calculation using G*Power version 3.1.10, 48 applying a 2-tailed t-test of the difference between 2 independent means with an effect size of 0.5, an a priori α error level of .05, and a power of 0. were conducted to determine whether the groups were different in terms of their association with the 4 outcomes after adjusting for potential confounders. Variables that were statistically significant when tested against the treatment group and also associated with EN-related and GC outcomes were included in the multivariable analyses as covariates.
To include both strong and moderate confounders in the multivariable model, we used a more liberal P-value cutoff (<.10). In addition, variables considered clinically relevant (age, APACHE II score, BMI, and history of diabetes) to the outcomes were included in the models. Percent of prescribed energy and protein delivered and GV were analyzed using multiple linear regression. Number of days with hyperglycemia was dichotomized as absence (0 days) or presence (ࣙ1 days) of hyperglycemia and analyzed using logistic regression. The analyses were conducted using Statistical Package for Social Sciences (SPSS) version 23 (Armonk, NY, USA), and statistical significance was established at P ࣘ .05.
Results
Between January 1, 2015, and February 28, 2017, a total of 864 patients with a VBEN or RBEN order were identified from the Active Tube Feeding Orders Report. A total of 171 (19.8%) patients met inclusion criteria, and 693 (80.2%) were excluded ( Figure 2 ). The RBEN and VBEN groups included 85 and 86 patients, respectively. Demographic and clinical characteristics are presented for all patients and by treatment group in Table 1 . The RBEN and VBEN groups were significantly different in terms of their ICU admission location and primary diagnosis. Within the RBEN group, more patients were admitted to the cardiothoracic surgical/organ transplant and medical cardiology ICUs, whereas in the VBEN group, more patients were admitted to the medical, medical cardiology, and trauma ICUs. The most prevalent primary diagnoses in the RBEN group were cardiovascular/vascular and respiratory diseases, whereas the most common primary diagnoses in the VBEN group were respiratory and neurological diseases. The VBEN group had significantly more days with an EN order (P = .01), as well as a higher percentage of days with fever (P = .04), compared with the RBEN group. Other demographic and clinical characteristics were not different between the groups.
EN was initiated on ICU day 1.3 (mean) for the total sample (Table 2) . EN was initiated significantly earlier in the VBEN group vs the RBEN group (P < .001). Fifty percent of the VBEN group initially had an RBEN order for a mean of 1 day before a VBEN order, and the other 50% had VBEN as their initial order. All patients received EN for a mean of 6.7 days, whereas the VBEN group received EN for significantly more days than the RBEN group (7.4 vs 6.0 days; P = .002). Although gastric tubes were used in the majority of patients in both groups, they were more prevalent in the VBEN group vs the RBEN group (P < .001). The EN prescription for energy and protein was not different between the groups. However, the VBEN group received 202 more calories and 12 more g of protein per day compared with the RBEN group (P < .001). Both groups received a similar amount of energy per day from propofol and IV dextrose, but the VBEN group received significantly more total energy from all sources (EN, propofol, IV dextrose) compared with the RBEN group (P = .001). In addition, the RBEN group had a significantly higher percentage of days with a corticosteroid order (P = .01).
The percentages of prescribed energy and grams of protein received were significantly higher in the VBEN group vs the RBEN group (P < .001) ( Table 3 ). The VBEN group received 79.6% of prescribed energy and 79.3% of prescribed protein, whereas the RBEN group received 67.6% and 68.6%, respectively. Absence or presence of hyperglycemia and GV were not different between the 2 groups (Tables 3 and 4 ). The VBEN group had 53 (61.6%) patients with presence of hyperglycemia compared with 47 (55.3%) in the RBEN group (P = .40). GV was similar at 25.5% in the RBEN group and 24.6% in the VBEN group (P = .99).
Covariates relevant to or associated with the treatment and outcomes of interest were included in the multivariable models. In multiple linear regression models, a VBEN order, compared with RBEN, was significantly associated with an 8.9% and 7.7% increase in percent of energy and protein received, respectively, even after adjusting for age, APACHE II score, duration of EN, ICU day EN was initiated, and ICU admission location (Table 3) . Neither presence nor absence of hyperglycemia based on the first morning blood glucose level or GV was significantly related to type of EN order (Tables 3 and 4) , even after taking into account age, BMI, primary diagnosis, history of diabetes, and percent of ICU days with a corticosteroid order.
Discussion
This study adds to existing research establishing the role of VBEN in improving EN delivery without increasing complications. The results support our hypotheses that VBEN, compared with RBEN, increases percent of prescribed energy and protein delivered. In addition, our hypotheses that there would be no difference between groups for GC outcomes are supported.
Our study showed that VBEN compared with RBEN led to a modest improvement in prescribed energy and protein delivered. The majority of other studies comparing EN delivery between RBEN and VBEN have found a similar or lower incremental increase. 30, 31, 33, 35, 36 Although the improvement was modest, the increased delivery of energy and protein (200 more calories and 12 more g of protein per day) (Table 2 ) on a daily basis is clinically important for minimizing nutrition deficits, which have been associated with poor outcomes, including higher mortality. 12, 16, 20, 23 A target of delivering ࣙ80% of prescribed EN has been established and adopted at BUMC as a quality metric to improve clinical outcomes, including mortality, time to discharge from the ICU, and discharge destination. 16, 18, 21 The VBEN group received close to 80% of prescribed energy and protein vs 68% in the RBEN group. This accomplishment is notable because audits of EN delivery in ICUs across the world have shown delivery of prescribed EN at 65%-70%. 25 In addition, our multiple linear regression model confirmed a VBEN order was significantly associated with increased delivery of prescribed energy and protein even after adjusting for confounders.
Differences were seen between the RBEN and VBEN groups in terms of their ICU admission location. These differences reflect the practice patterns in the admission ICUs. In the cardiothoracic surgical/organ transplant ICU, clinicians were hesitant to use VBEN due to concerns about tolerance of VBEN, which could potentially allow an EN delivery rate up to 150 mL/h, after a major surgery frequently involving the abdomen or lungs. The less frequent use of VBEN in the medical cardiology ICU was related to patients on a hypothermia protocol after cardiac arrest, who either had delayed initiation of enteral feedings and/or were receiving rate-based trophic feedings. In both of these patient populations, concerns about aspiration and gastrointestinal ischemia impacted the type of EN prescription. Of note, none of the patients receiving VBEN received >2400 mL (ie, 100 mL/h) in a 24-hour period. In addition, a small number of patients in these ICUs received and tolerated VBEN. The perceived fear of intolerance vs actual intolerance needs to be studied further. Future research should explore whether these patients can tolerate VBEN without negative consequences. Lack of compliance with VBEN orders and poor implementation of an EN protocol have been reported by others and credited for inadequate EN delivery. 28, 36 Nursing compliance with VBEN orders was not evaluated in this study and could have influenced the results. Due to the large number of nurses practicing in BUMC ICUs, training to ensure compliance is challenging. However, we frequently provide training and feedback of internal audit results to nursing leaders and staff to highlight the importance of VBEN compliance. We have also engaged physician leaders to champion VBEN. These strategies seem to be working because our internal real-time audits using data from the EN infusion pump demonstrate patients are receiving a mean of 84% of prescribed EN, only slightly higher than the 80% found in this study. These tactics and others have been shown to be essential to sustain compliance. 11 In a quality improvement study, Taylor et al 24 achieved a 26% increase in delivery of prescribed EN after implementing VBEN. The magnitude of improvement is likely due to their extensive efforts to engage all stakeholders, educate nurses, and monitor compliance with VBEN on an ongoing basis.
Time to achieve the EN goal rate and an initial RBEN order are other factors that could have contributed to our modest increase in delivery of prescribed EN. We did not collect data to determine how long it took to achieve EN goal rate in this study. However, in a previous study in ICU patients receiving VBEN at our hospital, the median time to reach goal rate was on ICU day 3. 34 Also, 50% of patients receiving VBEN initially received RBEN for 1 day, which frequently was infusing at 20 mL/h per the MV order set. Clinicians have speculated high EN infusion rates possible with VBEN could negatively impact GC. We and others have demonstrated GC, based on the first morning blood glucose level, is equivalent with VBEN compared with RBEN. 24, 28, 31, [34] [35] [36] We are unaware of research related to VBEN and GV, which is a more comprehensive measurement of GC because it is calculated using all blood glucose levels. This study is the first to compare GV with RBEN and VBEN, and we did not find any difference between the groups. Although no known research using VBEN has evaluated GV, a study comparing bolus vs continuous EN in the ICU also did not report any difference in GV. 49 Because blood glucose levels can be influenced by many factors, such as a fever and infection, history of diabetes, and corticosteroid use, we collected these variables and evaluated their relationship with GC outcomes. The VBEN group had a higher percent of ICU days with fever and a lower percent of ICU days with a corticosteroid order vs the RBEN group, which could have influenced our results. However, when controlling for covariates in multivariable analyses, only a history of diabetes, age, and BMI significantly impacted GC outcomes.
This study has several strengths. The principal investigator executed a very detailed data collection process and was the only individual extracting data from the EHR, which can minimize variance in data interpretation. In addition, every 10th patient's data were rechecked by the principal investigator as a means to validate data accuracy. The inclusion and exclusion criteria were established to ensure adequate exposure to either RBEN or VBEN. The required sample size based on the power analysis was exceeded, and there were very little missing data in the EHR. The 2 groups were well matched for most demographic and clinical characteristics, including indicators of acuity such as APACHE II score, duration of MV, and ICU LOS. We also collected data to account for potential confounders and carried out a multivariable analysis, which has not been conducted in most related studies to date.
The study also has several limitations, including its design, which was a retrospective, nonrandomized design precluding causality and allowing inference only on associations between treatments and outcomes. Because the study was conducted at a single center, generalization of results to other geographical locations may not be possible. However, this limitation may be mitigated by inclusion of both medical and surgical patients admitted to 5 different ICU locations. Mortality is an important outcome, and we did not evaluate it in this study. This study was powered to evaluate the primary outcome of delivery of prescribed EN. Future research should focus on mortality, as well as quality of life, and functional status as outcomes in relation to effectiveness of VBEN vs RBEN. Although we controlled for several factors that could impact GC, additional research in this area is warranted to strengthen the evidence regarding whether VBEN has a negative influence on GC. Areas of interest include the impact of VBEN vs other factors on percent of time blood glucose levels are >200 mg/dL and proactive insulin adjustment based on increases in carbohydrate delivery when the EN rate is increased with a VBEN order. In addition, the incidence of hypoglycemic episodes with VBEN compared with RBEN should be studied. Other limitations include potential for inaccurate data entry in the EHR and compliance with VBEN orders.
Conclusion
VBEN, compared with RBEN, is associated with increased delivery of energy and protein from EN. In addition, VBEN vs RBEN was not associated with higher incidence of hyperglycemia or GV. These results suggest that VBEN is an effective and safe strategy for ICU patients who are vulnerable to underfeeding, malnutrition, and related negative outcomes. Because multiple studies have shown that underfeeding is prevalent in ICUs across the world, 12, 14, 17, 18 clinicians practicing in the ICU should consider implementing VBEN and other strategies, such as starting EN at target goal rate, to improve EN delivery.
